Replies to post #183850 on Biotech Values

[HobGlobulin]

How did ISIS become a party to this litigation?


I don’t know the details.

In 1998 Isis began a collaboration with Merck on HCV:

http://www.wikinvest.com/stock/Isis_Pharmaceuticals_(ISIS)/Merck_Inc


In 2002 Isis’s GeneTrove division did work for Merck (pardon the rhyme):

http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-newsArticle&ID=1290295&highlight=


Hob